These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 3119204
1. Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas. Prados M, Rodriguez L, Seager M, Silver P, Levin V. Cancer Treat Rep; 1987 Nov; 71(11):1105-6. PubMed ID: 3119204 [No Abstract] [Full Text] [Related]
2. A phase I trial of spirohydantoin mustard (NSC 172112) in patients with advanced cancer. Brown TD, Ettinger DS, Donehower RC. J Clin Oncol; 1986 Aug; 4(8):1270-6. PubMed ID: 3525770 [Abstract] [Full Text] [Related]
3. A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. Heideman RL, Kelley JA, Packer RJ, Reaman GH, Roth JS, Balis F, Ettinger LJ, Doherty KM, Jeffries SL, Poplack DG. Cancer Res; 1988 Apr 15; 48(8):2292-5. PubMed ID: 3349492 [Abstract] [Full Text] [Related]
4. Spiromustine and intracarotid artery cisplatin in the treatment of glioblastoma multiforme. Resio MJ, DeVroom HL. J Neurosci Nurs; 1986 Feb 15; 18(1):13-22. PubMed ID: 3005442 [Abstract] [Full Text] [Related]
5. Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group. Eur J Cancer Clin Oncol; 1985 Jan 15; 21(1):143-6. PubMed ID: 4038653 [No Abstract] [Full Text] [Related]
6. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD. Clin Cancer Res; 2006 Aug 15; 12(16):4899-907. PubMed ID: 16914578 [Abstract] [Full Text] [Related]
7. [The effect of phenesterin on glial tumors of the mouse brain]. Iablonovskaia LIa, Degteva SA. Arkh Patol; 1965 Aug 15; 27(12):60-3. PubMed ID: 5875703 [No Abstract] [Full Text] [Related]
8. Effect of DDMP (2, 4-diamino-5-3', 4'-dichlorophenyl-6-methylpyrimidine) on brain gliomas--a phase II study. E.O.R.T.C. Brain Tumor Group. Eur J Cancer (1965); 1980 Dec 15; 16(12):1639-40. PubMed ID: 7227437 [No Abstract] [Full Text] [Related]
9. Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line. Da Silva VF, Raaphorst GP, Goyal R, Feeley M. J Neurosurg; 1987 Dec 15; 67(6):885-8. PubMed ID: 3681426 [Abstract] [Full Text] [Related]
10. Phase II evaluation of vindesine in the treatment of malignant glioma. Alavi JB, Weiler CB, Bruno LA. Cancer Treat Rep; 1984 May 15; 68(5):807-8. PubMed ID: 6722835 [No Abstract] [Full Text] [Related]
11. The effect of treatment with single and split doses of spirohydantoin mustard on the growth delay of 9L rat brain tumor multicellular spheroids. Jostes RF, Williams ME, Deen DF. Eur J Cancer Clin Oncol; 1985 Aug 15; 21(8):975-9. PubMed ID: 4043180 [Abstract] [Full Text] [Related]
12. [Chemotherapy of malignant brain tumors by intermittent and continuous intra-arterial infusion of antitumor agents--clinical study]. Sato O. No To Shinkei; 1966 Nov 15; 18(11):1103-21. PubMed ID: 4292939 [No Abstract] [Full Text] [Related]
13. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Yung WK, Kyritsis AP, Gleason MJ, Levin VA. Clin Cancer Res; 1996 Dec 15; 2(12):1931-5. PubMed ID: 9816151 [Abstract] [Full Text] [Related]
14. Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model. Pazdur R, Redman BG, Corbett T, Phillips M, Baker LH. Cancer Res; 1987 Aug 01; 47(15):4213-7. PubMed ID: 3607760 [Abstract] [Full Text] [Related]
15. Imidazole carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II clinical trial of 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumors. Levin VA, Crafts D, Wilson CB, Kabra P, Hansch C, Boldrey E, Enot J, Neely M. Cancer Chemother Rep; 1975 Aug 01; 59(2 Pt 1):327-31. PubMed ID: 1149010 [No Abstract] [Full Text] [Related]
16. [Therapeutic effect of human lymphoblastoid interferon (MOR-22) on malignant brain tumors--a phase II study]. Hirakawa K. Nihon Gan Chiryo Gakkai Shi; 1986 Jun 20; 21(5):1068-74. PubMed ID: 3760650 [No Abstract] [Full Text] [Related]
17. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY. Neuro Oncol; 2007 Jul 20; 9(3):354-63. PubMed ID: 17452651 [Abstract] [Full Text] [Related]
18. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB. J Clin Oncol; 2003 Jun 15; 21(12):2299-304. PubMed ID: 12805330 [Abstract] [Full Text] [Related]
19. Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas. Doherty L, Gigas DC, Kesari S, Drappatz J, Kim R, Zimmerman J, Ostrowsky L, Wen PY. Neurology; 2006 Jul 11; 67(1):156-8. PubMed ID: 16832099 [Abstract] [Full Text] [Related]